Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
ACBMAcro Biomedical Co., Ltd.
| Figure | ACBMAcro Biomedical Co., Ltd.FY2025 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $101.15K |
| Net income, yoy | −139.1% |
| Net margin | — |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed